Virtus Fund Advisers’s Gilead Sciences GILD Stock Holding History

Virtus Fund Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$4.41M	Buy	61,617 +11,735	+24%	+$891K	0.04%	235
2017 Q3	$4.04M	Buy	+49,882	New	+$3.81M	0.04%	246
2017 Q1	–	Sell	-455,308	Closed	-$32.6M	–	537
2016 Q4	$32.6M	Sell	455,308 -15,005	-3%	-$1.12M	0.28%	138
2016 Q3	$37.2M	Buy	470,313 +1,915	+0.4%	+$156K	0.33%	121
2016 Q2	$39.7M	Sell	468,398 -9,526	-2%	-$845K	0.35%	106
2016 Q1	$43.9M	Buy	477,924 +5,343	+1%	+$482K	0.39%	108
2015 Q4	$47.8M	Sell	472,581 -1,078	-0.2%	-$112K	0.42%	88
2015 Q3	$46.5M	Buy	473,659 +406	+0.1%	+$45.1K	0.41%	94
2015 Q2	$55.4M	Buy	473,253 +11,862	+3%	+$1.3M	0.41%	91
2015 Q1	$45.3M	Sell	461,391 -44,238	-9%	-$4.49M	0.34%	111
2014 Q4	$47.7M	Sell	505,629 -112,188	-18%	-$11.6M	0.35%	109
2014 Q3	$65.8M	Sell	617,817 -16,202	-3%	-$1.59M	0.5%	76
2014 Q2	$52.6M	Buy	+634,019	New	+$49.4M	0.37%	109

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtus Fund Advisers's GILD Position: Q4 2017 in Review

Virtus Fund Advisers increased its Gilead Sciences (GILD) stake by 24% in Q4 2017, buying an estimated $891K and bringing the position to 61,617 shares worth $4.41M. The position accounts for 0.04% of the portfolio, ranked #235.

Virtus Fund Advisers first reported a position in GILD in Q2 2014 and has held it in 13 quarters since. The position peaked at $65.8M in Q3 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Virtus Fund Advisers held 61,617 shares of Gilead Sciences worth $4.41M as of Q4 2017.
Virtus Fund Advisers bought 11,735 Gilead Sciences shares in Q4 2017, an estimated $891K.
Gilead Sciences made up 0.04% of Virtus Fund Advisers's portfolio in Q4 2017, its #235 holding.
Virtus Fund Advisers first reported a position in Gilead Sciences in Q2 2014 and has held it in 13 quarters since.
Virtus Fund Advisers's Gilead Sciences position peaked at $65.8M in Q3 2014.
1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.